Market Cap 8.04B
Revenue (ttm) 3.03B
Net Income (ttm) -1.43B
EPS (ttm) N/A
PE Ratio 5.14
Forward PE 7.22
Profit Margin -47.23%
Debt to Equity Ratio 0.65
Volume 4,217,300
Avg Vol 2,563,398
Day's Range N/A - N/A
Shares Out 173.30M
Stochastic %K 1%
Beta 1.31
Analysts Sell
Price Target $58.71

Company Profile

Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland,...

Industry: REIT - Office
Sector: Real Estate
Phone: 626 578 0777
Fax: 626 578 0896
Website: www.are.com
Address:
26 North Euclid Avenue, Pasadena, United States
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 10:53 PM
$ARE The market hates logical analysis but I’m gonna provide some anyways. First off it’s no secret that different REITs will a command significantly different valuations and it is often difficult to compare two directly. However let’s work with a key assumption that $BXP AND $ARE both have some key similarities. Namely 1. They both provide premium office real estate in premium US hubs. (ARE does only lab space) 2. They are both industry leaders 3. They are both facing potential headwinds from occupancy and supply Now let’s consider the indisputable facts that $ARE has significantly stickier tenants and a much stronger moat in its respective industry. Let’s also consider that $ARE’s occupancy rate is currently 4% higher, and their debt to equity ratio is extremely trim compared to BXPs high leverage and weaker cash position. Lets also consider that lab space is a lot more “necessary” than traditional office space in the sense that wet labs are in person research is a requirement
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 10:13 PM
$ARE scratch that, the P/FFO is actually 6.7X after today. If it doubled in price it would be at the low end of its historical average of around 14X. Occupancy is at 90%, a majority of the biggest blue chip leases don’t expire dor 7+ years.
0 · Reply
Arb_raccoon
Arb_raccoon Apr. 1 at 8:55 PM
$ARE Entering here - see you boys at $200
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 8:26 PM
$ARE bro the P/FFO is literally at like 7X that’s the same as some mall REITs were before they went bankrupt. The current occupancy rate is 90% after a five-year biotech bear market that will likely as soon recover 😭😭
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 7:47 PM
$ARE Adjusted for inflation this is way below all time lows, in fact anything below $50 is basically priced at all time lows. While the company is in a position that is far stronger than 75% of its lifespan
2 · Reply
StockFactz
StockFactz Apr. 1 at 7:40 PM
$ARE High-quality lab space in core innovation hubs will always be valuable, and profitable
1 · Reply
StockFactz
StockFactz Apr. 1 at 7:34 PM
$ARE - "The price fell because the dividend fell" No actually the dividend is higher than it was in 2013 and similar to 2015 where it was trading at double the price. - "The stock has P/FFO ratio that is too high and needs to be adjusted for market headwinds" Well no, actually it is trading at historic lows, close to 1/3 of previous highs and 1/2 of previous lows. The P/FFO is so low it's essentially being priced like a 50 year old decaying office building in Detroit when the real estate they own sits in the most luxurious and high end business/health centers in the world, and has proven high demand even with market headwinds.
0 · Reply
Arcides
Arcides Apr. 1 at 7:27 PM
$ARE will this garbage go to the 2009 low (30.33)?
1 · Reply
Koapark
Koapark Apr. 1 at 7:26 PM
$ARE Impressive sell off to say the least. For no particular reason. I’ve always had 35 as a target, not because I think that’s how the company should be valued but because the market almost always overshoots upside and downside. It’s a screaming buy now. Will be even more insane buy in the 30s - I’ll be loading my bag bigly
0 · Reply
StockFactz
StockFactz Apr. 1 at 7:12 PM
$ARE THIS IS GENERATIONAL FREE MONEY!!!!! When it hits $65 in a couple months I will make a clean $40K plus all the dividends
0 · Reply
Latest News on ARE
Conflict Without Closure

Mar 29, 2026, 9:00 AM EDT - 3 days ago

Conflict Without Closure

AGG AGNC AGNCM AGNCN AGNCO AGNCP AHRT


5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 10 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

BME DOC HQH PFE


What Active REIT Managers Bought And Sold In Q4 2025

Mar 21, 2026, 7:15 AM EDT - 12 days ago

What Active REIT Managers Bought And Sold In Q4 2025

ADC AHR AMH AVB CCI CNS CPT


Alexandria Real Estate: A Long-Term Approach Is Required

Mar 16, 2026, 8:00 AM EDT - 16 days ago

Alexandria Real Estate: A Long-Term Approach Is Required


Aecon Group Inc. (ARE:CA) Q4 2025 Earnings Call Transcript

Mar 6, 2026, 2:55 PM EST - 26 days ago

Aecon Group Inc. (ARE:CA) Q4 2025 Earnings Call Transcript


Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 4 weeks ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR BBY BEN BXP CAG CCI CPB


Private Credit Default Rates Could Hit 15%, UBS Warns

Feb 25, 2026, 10:59 AM EST - 5 weeks ago

Private Credit Default Rates Could Hit 15%, UBS Warns

ARES BX OWL


Alexandria Real Estate Q4 Results: The Good, The Bad, The Ugly

Feb 10, 2026, 7:50 AM EST - 7 weeks ago

Alexandria Real Estate Q4 Results: The Good, The Bad, The Ugly


1 Popular REIT To Sell And 1 Hated REIT To Buy

Jan 27, 2026, 8:50 AM EST - 2 months ago

1 Popular REIT To Sell And 1 Hated REIT To Buy

VNQ WELL


Here's How Not To Invest $100,000 In 2026

Jan 21, 2026, 12:08 PM EST - 2 months ago

Here's How Not To Invest $100,000 In 2026

BTI CAG DOW ECC IBM NEE SCHD


Powell Under Pressure

Jan 19, 2026, 9:00 AM EST - 2 months ago

Powell Under Pressure

AGG AGNC AGNCM AGNCN AGNCO AGNCP AHT


ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 10:53 PM
$ARE The market hates logical analysis but I’m gonna provide some anyways. First off it’s no secret that different REITs will a command significantly different valuations and it is often difficult to compare two directly. However let’s work with a key assumption that $BXP AND $ARE both have some key similarities. Namely 1. They both provide premium office real estate in premium US hubs. (ARE does only lab space) 2. They are both industry leaders 3. They are both facing potential headwinds from occupancy and supply Now let’s consider the indisputable facts that $ARE has significantly stickier tenants and a much stronger moat in its respective industry. Let’s also consider that $ARE’s occupancy rate is currently 4% higher, and their debt to equity ratio is extremely trim compared to BXPs high leverage and weaker cash position. Lets also consider that lab space is a lot more “necessary” than traditional office space in the sense that wet labs are in person research is a requirement
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 10:13 PM
$ARE scratch that, the P/FFO is actually 6.7X after today. If it doubled in price it would be at the low end of its historical average of around 14X. Occupancy is at 90%, a majority of the biggest blue chip leases don’t expire dor 7+ years.
0 · Reply
Arb_raccoon
Arb_raccoon Apr. 1 at 8:55 PM
$ARE Entering here - see you boys at $200
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 8:26 PM
$ARE bro the P/FFO is literally at like 7X that’s the same as some mall REITs were before they went bankrupt. The current occupancy rate is 90% after a five-year biotech bear market that will likely as soon recover 😭😭
1 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 7:47 PM
$ARE Adjusted for inflation this is way below all time lows, in fact anything below $50 is basically priced at all time lows. While the company is in a position that is far stronger than 75% of its lifespan
2 · Reply
StockFactz
StockFactz Apr. 1 at 7:40 PM
$ARE High-quality lab space in core innovation hubs will always be valuable, and profitable
1 · Reply
StockFactz
StockFactz Apr. 1 at 7:34 PM
$ARE - "The price fell because the dividend fell" No actually the dividend is higher than it was in 2013 and similar to 2015 where it was trading at double the price. - "The stock has P/FFO ratio that is too high and needs to be adjusted for market headwinds" Well no, actually it is trading at historic lows, close to 1/3 of previous highs and 1/2 of previous lows. The P/FFO is so low it's essentially being priced like a 50 year old decaying office building in Detroit when the real estate they own sits in the most luxurious and high end business/health centers in the world, and has proven high demand even with market headwinds.
0 · Reply
Arcides
Arcides Apr. 1 at 7:27 PM
$ARE will this garbage go to the 2009 low (30.33)?
1 · Reply
Koapark
Koapark Apr. 1 at 7:26 PM
$ARE Impressive sell off to say the least. For no particular reason. I’ve always had 35 as a target, not because I think that’s how the company should be valued but because the market almost always overshoots upside and downside. It’s a screaming buy now. Will be even more insane buy in the 30s - I’ll be loading my bag bigly
0 · Reply
StockFactz
StockFactz Apr. 1 at 7:12 PM
$ARE THIS IS GENERATIONAL FREE MONEY!!!!! When it hits $65 in a couple months I will make a clean $40K plus all the dividends
0 · Reply
JPEstrada
JPEstrada Apr. 1 at 7:11 PM
$ARE the one and 5 year charts on this piece of shit look terrible. Just bleeding. Sitting out for further crashing.
1 · Reply
StockFactz
StockFactz Apr. 1 at 7:09 PM
$ARE Don't freak out longs, enjoy the free money
1 · Reply
StockFactz
StockFactz Apr. 1 at 7:02 PM
$ARE Picked up another $15K will hold like $30K in reserve hopefully I dont regret not jumping on the buy opportunity with more
0 · Reply
StockFactz
StockFactz Apr. 1 at 7:00 PM
$ARE Lowkey considering using $40-50K of margin on this right now....... this is how insane I feel like the price is right now. I've never seen anything like this for a REIT or similar genres of equity
1 · Reply
StockFactz
StockFactz Apr. 1 at 6:51 PM
$ARE -6% for no reason (-54% last 1Y) while market rips up including biotech, this is completely unreasonable, I always buy divergence from common sense
1 · Reply
sceptre_sights
sceptre_sights Apr. 1 at 6:50 PM
$ARE is this april fools? Added some. Which institutions are capitulating out?
2 · Reply
StockFactz
StockFactz Apr. 1 at 6:48 PM
$ARE Screw it I'm gonna double my position! Averaging down and picking up 1,000 more shares
0 · Reply
qqqweeklies
qqqweeklies Apr. 1 at 6:47 PM
$ARE this is insane
1 · Reply
StockFactz
StockFactz Apr. 1 at 6:46 PM
$ARE This is so tasty 🤤 I love when someone sells me a $100 bill for $43.
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 6:37 PM
$ARE Went from being up 18% to being down 14% in 2 months off of basically no real stock specific news, crazy stuff
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 6:32 PM
$ARE Picked up 50 more for around $2K here
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 1 at 6:30 PM
$ARE broke low of December, some of the dumbest price action I’ve witnessed in 10+ years. Although I’m quite confident this is literally as low as it can go
0 · Reply